COMP <GO>
ENOV vs ZJYL // EV/EBITDA & P/E VALUATION
Enovis Corporation (NYSE) VS. JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) • 15-METRIC TALLY: ENOV 5
— ZJYL 3
■ METRIC PARITY
LAST: $19.91 (-12.71%) • MKT CAP: $1.15B
valuation
—
LAST: $2.35 (+26.34%) • MKT CAP: $371.8M
valuation
47.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENOV VS. ZJYL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENOV | ZJYL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.80% | 29.20% | +30.60 | ENOV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.70% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 47.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.51% | -1.27% | +2.78 | ENOV | /fcf-yield <GO> |
| Operating Margin | -50.00% | 2.90% | -52.90 | ZJYL | /operating-margins <GO> |
| Net Profit Margin | -52.70% | 5.80% | -58.50 | ZJYL | /net-margins <GO> |
| Revenue Growth (YoY) | 6.70% | -12.00% | +18.70 | ENOV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | ENOV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.2 | 57.0 | -8.80 | ZJYL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.15B | $371.8M | $776.4M | ENOV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENOV REV | ZJYL REV | ENOV GROSS % | ZJYL GROSS % | ENOV FCF | ZJYL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.25B | $20.7M | 59.8% | 29.2% | $19.9M | -$3.7M |
| FY 2024 | $2.11B | $23.5M | 56.0% | 40.4% | -$67.2M | -$1.4M |
| FY 2023 | $1.71B | $19.8M | — | — | $135.0M | $3.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENOV // BETA —
ZJYL // BETA —